Funding Search - Pivot

The University of Vermont, through Sponsored Project Administration (SPA) subscribes to Pivot, a web-based funding search tool. The UVM Cancer Center has collaborated with SPA to create a customized cancer relevant pivot search. Press the button for Cancer Funding Opportunities.

Cancer Funding Opportunities

If you would prefer to set up your own pivot search and automated alerts you can learn more about pivot HERE.

For Pivot Assistance

Please review the information provided by SPA

Hilda Alajajian, Grant Resources Specialist is available to meet with individuals or groups for assistance in identifying funding

Phone: (802)656-1322

Should you learn of an opportunity not listed here but important to UVM Cancer Center research, please contact Laura Gordon.

Limited Competition Funding

Please contact Edward North for information on applying for Limited Funding Opportunities. 

Peer-Reviewed Funding Sources

Below is a list of fund sources from federal agencies, non-profit foundations and regional and national organizations to support cancer research are provided below for UVM Cancer Center researchers. This of funding is considered NCI approved peer-reviewed funding and can also be found in PDF format at the following link: NCI Peer-Reviewed Fund Sources

  1. Agency for Healthcare Research and Quality (AHRQ)
  2. Alex’s Lemonade Stand Foundation (ALSF)
  3. American Association of Cancer Research (AACR)
  4. American Cancer Society (ACS) (national office only)
  5. American Foundation for AIDS Research (amfAR)
  6. American Institute for Cancer Research (AICR)
  7. California Institute for Regenerative Medicine (CIRM)
  8. Cancer Prevention Research Institute of Texas (CPRIT)
  9. Center for Disease Control and Prevention (CDC)
  10. Central Office of the Veterans Administration (VA) (excluding local/regional & “block” grants)
  11. Environmental Protection Agency (EPA)
  12. The Flight Attendant Medical Research Institute (FAMRI)
  13. Florida Biomedical Research Program (FBRP)
  14. Food and Drug Administration (FDA)
  15. Howard Hughes Medical Institute (HHMI)
  16. Leukemia and Lymphoma Society (LLS)
  17. Melanoma Research Alliance (MRA)
  18. Multiple Myeloma Research Foundation (MMRF)
  19. National Institute for Occupational Safety and Health (NIOSH)
  20. National Science Foundation (NSF)
  21. New York State Department of Health Wadsworth Center/New York State Stem Cell Science Program (NYSTEM)
  22. Patient-Centered Outcomes Research Institute (PCORI)
  23. Prevent Cancer Foundation (PCF)
  24. Prostate Cancer Foundation (PCF)
  25. Susan G. Komen for the Cure
  26. The California Breast Cancer Research Program (CBCRP)
  27. The California Tobacco Related Disease Research Program (TRDRP)
  28. U.S. Army (DOD) special research programs *

Highlights: New & Updated

New and Updated

The Doris Duke Charitable Foundation (DDCF) has issued a Request for Applications for Physician Scientist Fellowships

  • One to two-year awards
  • $100,000 per year direct
  • Supports clinical research project
  • Applicant must have MD, MD/PhD, DO (or foreign equivalent) degree
  • Applicant must have US medical license and be in subspecialty training
  • Mentorship plan required
  • Women and members of underrepresented groups strongly encouraged
  • Animal research not supported
  • Assistant Professors not eligible

Applications due June 7, 2019 at 3 PM ET


Alex's Lemonade Stand - Psychosocial Family Impact Grant -

TheALSF Psychosocial Family Impact Grant will fund $300,000 over three years forstudies that aim to explain and/or improve psychosocial outcomes of thoseaffected by childhood cancer. These grants are designed to fundresearchers who have novel approaches to understanding the psychosocial aspectsof pediatric cancer and whose proposals will have a clinically significantimpact.

LOI/Pre-Application Due Date of June 17, 2019 


Alex's Lemonade Stand - Psychosocial Launch Grant -

PsychosocialGrants fill a direct need for research funding by supporting studies that aimto explain and/or improve psychosocial outcomes of those affected by childhoodcancer. These grants are designed to fund researchers who have novel approachesto understanding the psychosocial aspects of pediatric cancer and whoseproposals will have a clinically significant impact.

LOI/Pre-Application Due Date of June 17, 2019 


The Integrated Approach to Breast Health Equity program announced below is a joint collaboration between Pfizer Global Medical Grants and the American Cancer Society which:

  • Supports research on reducing the widening gap in breast cancer mortality trends between black and white patients
  • Requires joint grant applications between multiple sectors (e.g., academic centers      & community health centers or hospitals & FQHCs)
  • Provides up to $350,000 for Community Engaged Projects for innovative,      communitywide, clinical practice or health systems engaged projects
  • Provides up to $50,000 for Formative Projects focusing on assessment onl
  • Does not support clinical research projects

LOI Due Date of June 17, 2019

PFIZER-LCRF Competitive Research Grant -  

The Lung Cancer ResearchFoundation and Pfizer Global Medical Grants are collaborating to offer a newresearch grant opportunity focused on understanding ways to improve clinicalpractices for side effect management for non-small cell lung cancer (NSCLC)patients receiving targeted therapies. This collaborative funding mechanism isdesigned to support innovative health services research proposals that leveragemultidisciplinary approaches to improve the management of targeted therapytoxicities.

LOI/Pre-Application Due Date of June 24, 2019 


Melanoma Research Program - Idea Award -

The goal of the MRPis to prevent melanoma initiation and progression. The mission of the MRP is tosupport earlier intervention to enhance mission readiness for U.S. militarypersonnel and to diminish the disease burden on Service members, Veterans, andthe American public.

The FY19 MRP Idea Awardsupports innovative, untested, high-risk/potentially high-reward concepts,theories, paradigms, and/or methods in melanoma research. The advancement ofknowledge in melanoma research, patient care, and/or treatment options in theMilitary Health System (MHS) is critical to active duty Service members,Veterans, other military beneficiaries, and the American public.

LOI/Pre-Application Due Date of June 26, 2019 


Prevent Cancer Foundation - Research Grants - ThePrevent Cancer Foundation will provide grant support for research into cancerprevention and early detection. For 2019, grants will be awarded for two yearsin the amount of $50,000 per year.

Due Date of June 28, 2019 



Prevent Cancer Foundation - Research Fellowships -

Thesponsor provides Fellowships designed to promote the sponsor's mission of theprevention of cancer through scientific research and education. Due Date of June 28, 2019


VHLA Research Grant Program -

VHLA’scompetitive research grant program is helping to elucidate the pathwaysinvolved in tumorigenesis including how to overcome the body signaling andresponse to what it perceives as a hypoxic (low oxygen) environment. TheVHL Alliance is dedicated to research, education, and support to improveawareness, diagnosis, treatment, and quality of life for those affected by vonHippel-Lindau.

LOI/Pre-Application Due Date of July 15, 2019 


Provocative Questions (PQs) in Multiple MyelomaDisparities Research (R21 Clinical Trial Optional) Or (R01 Clinical Trial Optional-

Through this Funding OpportunityAnnouncement (FOA), the National Cancer Institute (NCI) invites R21applications for exploratory/developmental research projects designed to solvespecific problems and paradoxes in multiple myeloma (MM) and disparitiesresearch identified as the NCI Multiple Myeloma Disparities ProvocativeQuestions (MMD PQs). These problems and paradoxes phrased as questions are notintended to represent the full range of NCI's priorities in multiple myelomaresearch. Rather, they are meant to challenge cancer researchers to think aboutand elucidate specific problems in key areas of multiple myeloma anddisparities research that are deemed important but have not received sufficientattention.

The FOA includes six Multiple Myeloma PQs that represent diverse fieldsrelevant to multiple myeloma disparities research, but all are framed toinspire interested scientists to conceive new approaches and/or feasiblesolutions. Each research project (application) proposed in response to this FOAmust be focused on addressing one particular research problem defined by onespecific MMD PQ selected from the list. Projects proposed to address specificMMD PQs may use strategies that incorporate ideas and approaches from multipledisciplines, as appropriate. Transdisciplinary projects are encouraged as longas they serve the scientific focus of the specific PQ chosen.

Due Date of July 15, 2019 

DoD Ovarian Cancer Research Program - Early Career Investigator Award; maximum $725,000 over four
years; interactive award with education included. Pre-application due July 25,